BACM
GHDX

Blue Arrow Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Blue Arrow Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,959
Closed -$112K – 258
2014
Q3 		$112K Buy
+3,959
New +$110K 0.01% 179
2014
Q2 		– Sell
-10,600
Closed -$279K – 189
2014
Q1 		$279K Buy
+10,600
New +$304K 0.04% 99

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blue Arrow Capital Management's GHDX Position: Q4 2014 in Review

Blue Arrow Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2014, closing a stake of 3,959 shares — an estimated $112K sold.

Blue Arrow Capital Management first reported a position in GHDX in Q1 2014 and held it in 2 quarters. The position peaked at $279K in Q1 2014. 113 funds tracked by Wall St. Rank hold GHDX as of Q4 2014.

  • Blue Arrow Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2014 after selling out during the quarter.
  • Blue Arrow Capital Management sold 3,959 Genomic Health, Inc. shares in Q4 2014, an estimated $112K.
  • Blue Arrow Capital Management first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 2 quarters.
  • Blue Arrow Capital Management's Genomic Health, Inc. position peaked at $279K in Q1 2014.
  • 113 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2014.

Based on Blue Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.